Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ACHV will rise by +4.74% over the next 2 Weeks and hit $6.47 by Wednesday, August 12, 2026. In that time frame, ACHV's share price is expected to range between $6.06 and $6.90.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 12, 2026 | 6.06 | 6.47 | 6.90 |
| Aug 11, 2026 | 6.10 | 6.51 | 6.94 |
| Aug 10, 2026 | 5.92 | 6.34 | 6.75 |
| Aug 7, 2026 | 5.89 | 6.30 | 6.74 |
| Aug 6, 2026 | 5.79 | 6.21 | 6.61 |
| Aug 5, 2026 | 5.88 | 6.31 | 6.76 |
| Aug 4, 2026 | 5.92 | 6.36 | 6.77 |
| Aug 3, 2026 | 5.75 | 6.19 | 6.59 |
| Jul 31, 2026 | 5.72 | 6.14 | 6.54 |
| Jul 30, 2026 | 5.63 | 6.06 | 6.44 |
ACHV shares rose +2.02% in Thursday, July 30, 2026's trading session, rising from a previous close of $6.18 to move at $6.30. The stock demonstrated notable intraday movement (see ACHV's key stats for a full breakdown), fluctuating between $6.08 and $6.34, a +4.28% trading range. While recent weeks have seen some volatility, ACHV has managed to secure a +0.48% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 828.77K shares changing hands, 450.51K fewer than the previous session. This amounted to $5.22M in total market activity.
Will ACHV Continue Its Upward Trend?
According to analyst ratings and projections for ACHV, Achieve Life Sciences, Inc. shares are anticipated to increase by +8.75%, potentially reaching $6.90 per share by August 12, 2026. Short-term technical indicators currently suggest a neutral sentiment for ACHV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the ACHV stock forecast, now is a good time to buy ACHV stock because its current trading price is -2.60% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ACHV covering social and institutional perspectives.
ACHV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ACHV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.85% to 56.50%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 55.89%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.57%, maintains a neutral outlook for the long term. Insights into ACHV's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Achieve Life Sciences Short-Term Forecasts
ACHV Forecast For Next 5 Days
Our algorithm anticipates Achieve Life Sciences (ACHV) stock could hit $6.50 by Aug 06, 2026. This represents a +3.10% fall from today's price, following a -3.00% change over the past five days.
ACHV Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Achieve Life Sciences, Inc. (ACHV) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $6.11, which would mean a -3.02% decrease from the current price of $6.30. Projections for this period range from a high of $7.01 to a low of $4.91.
ACHV Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Achieve Life Sciences's price over the next three months point to a rise. ACHV stock is expected to peak at $27.20 on Oct 30, 2026 after potentially dipping to $17.84 on Aug 06, 2026. On average, ACHV is likely to trade around $21.66 in the coming 90 days.
Achieve Life Sciences Stock Forecast 2025
Based on our predictive models, Achieve Life Sciences (ACHV) is expected to trade between $17.84 and $32.41 throughout 2026. This would result in an average price of $24.40, potentially offering investors a +287.30% return from current levels.
Achieve Life Sciences, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Achieve Life Sciences, Inc. (ACHV) is positioned to show a strong performance in July 2026. The price is predicted to move between $18.26 and $18.60, settling at an average of $18.43. This could translate to a +192.54% gain.
August 2026
Based on current market signals, Achieve Life Sciences, Inc. is projected to trend august 2026. We forecast a trading range from $17.84 to $21.42, with a likely average price of $19.74. Investors could expect a potential return of +213.33%.
September 2026
Our predictive algorithms indicate Achieve Life Sciences, Inc. stock may see a shift in September 2026. The expected range spans $20.20–$21.69, with an average target of $20.91. This represents a positive outlook and a possible gain of +231.90%.
October 2026
Analyzing established trends, Achieve Life Sciences, Inc. looks set to move in October 2026. Projections place the stock between $21.34 and $27.20, averaging around $24.53. This suggests a +289.37% gain from current levels.
November 2026
Market indicators suggest Achieve Life Sciences, Inc. could experience notable changes during November 2026. Prices could fluctuate within $27.14 to $32.41, with a midpoint forecast of $29.96. The stock might deliver a +375.56% gain.
December 2026
Forecasting for December 2026, models estimate that Achieve Life Sciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $24.23 and $31.97, averaging $27.30. This signals a positive trajectory with potential returns around +333.33%.
January 2027
According to our latest forecast models, Achieve Life Sciences, Inc. (ACHV) is positioned to show a strong performance in January 2027. The price is predicted to move between $24.52 and $31.34, settling at an average of $27.75. This could translate to a +340.48% gain.
February 2027
Based on current market signals, Achieve Life Sciences, Inc. is projected to trend february 2027. We forecast a trading range from $21.25 to $25.71, with a likely average price of $23.01. Investors could expect a potential return of +265.24%.
March 2027
Our predictive algorithms indicate Achieve Life Sciences, Inc. stock may see a shift in March 2027. The expected range spans $19.29–$24.13, with an average target of $21.22. This represents a positive outlook and a possible gain of +236.83%.
April 2027
Analyzing established trends, Achieve Life Sciences, Inc. looks set to move in April 2027. Projections place the stock between $19.05 and $26.14, averaging around $21.75. This suggests a +245.24% gain from current levels.
May 2027
Market indicators suggest Achieve Life Sciences, Inc. could experience notable changes during May 2027. Prices could fluctuate within $23.99 to $28.34, with a midpoint forecast of $25.50. The stock might deliver a +304.76% gain.
June 2027
Forecasting for June 2027, models estimate that Achieve Life Sciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $24.46 and $31.14, averaging $26.41. This signals a positive trajectory with potential returns around +319.21%.
July 2027
According to our latest forecast models, Achieve Life Sciences, Inc. (ACHV) is positioned to show a strong performance in July 2027. The price is predicted to move between $24.14 and $30.03, settling at an average of $25.86. This could translate to a +310.48% gain.
ACHV's history of dividends and stock splits also plays a role in long-term investor confidence.